AI brief of an SEC Form 8-K · AptarGroup (ATR)

AptarGroup names Gael Touya CEO and adds him to board effective September 1, 2026

Neutral Impact 4 of 5 leadership Written later

AptarGroup expanded its board from ten to eleven directors and appointed Gael Touya as a director effective September 1, 2026. Touya also became President and Chief Executive Officer that day, succeeding Stephan B. Tanda, who retired; the CEO change was previously disclosed in a March 17, 2026 filing. For shareholders, this filing confirms the leadership transition and board addition, with no financial results or guidance included.

Key points

  • Gael Touya appointed director effective September 1, 2026, with term expiring at the 2028 annual meeting.
  • Board size increased from ten to eleven directors on August 29, 2026.
  • Touya, formerly President of the Aptar Pharma segment, became CEO on September 1, 2026, succeeding Stephan B. Tanda.
  • Touya will not receive additional pay for board service; CEO compensation was disclosed in the March 17, 2026 8-K.

The filing

CompanyAptarGroup (ATR)
Form8-K, current report
Filed with the SECSep 1, 2026, 6:06 AM ET
Accession number0001104659-26-104037

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 01, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.